{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:37:04Z","timestamp":1778855824014,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ymthe.2024.05.020","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T05:50:39Z","timestamp":1715406639000},"page":"2328-2339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques"],"prefix":"10.1016","volume":"32","author":[{"given":"Midori","family":"Nakamura-Hoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takushi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trang Thi Thu","family":"Hau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Kuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ainai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Yonemitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Suzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Ami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3096-6749","authenticated-orcid":false,"given":"Tetsuro","family":"Matano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.05.020_bib1","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.05.020_bib2","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(20)30328-5","article-title":"Human T-cell lymphotropic virus type-1: a lifelong persistent infection, yet never truly silent","volume":"21","author":"Hirons","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.05.020_bib3","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.05.020_bib4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.05.020_bib5","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2024.05.020_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological Aspects and World Distribution of HTLV-1 Infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijid.2024.01.015","article-title":"Screening for HTLV-1 infection should be expanded in Europe","volume":"140","author":"Soriano","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.05.020_bib9","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S1473-3099(16)30252-3","article-title":"Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis","volume":"16","author":"Satake","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.05.020_bib10","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/s41591-018-0245-x","article-title":"Back in the spotlight","volume":"24","author":"Keener","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.05.020_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009915","article-title":"Very high prevalence of infection with the human T\u00a0cell leukaemia virus type 1c in remote Australian Aboriginal communities: Results of a large cross-sectional community survey","volume":"15","author":"Einsiedel","year":"2021","journal-title":"Plos Negl. Trop. Dis."},{"key":"10.1016\/j.ymthe.2024.05.020_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.897346","article-title":"The Past, Present, and Future of a Human T-Cell Leukemia Virus Type 1 Vaccine","volume":"13","author":"Tu","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.953650","article-title":"A role for an HTLV-1 vaccine?","volume":"13","author":"Ratner","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib14","first-page":"49","article-title":"Animal Models Utilized in HTLV-1 Research","volume":"4","author":"Panfil","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2024.05.020_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ijc.2910350113","article-title":"Infectious transmission of human T-cell leukemia virus to rabbits","volume":"35","author":"Miyoshi","year":"1985","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymthe.2024.05.020_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02123570","article-title":"Experimental infection of cynomolgus monkeys with a human retrovirus, adult T-cell leukemia virus","volume":"173","author":"Yamamoto","year":"1984","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ijc.2910380614","article-title":"Experimental inoculation of monkeys with autologous lymphoid cell lines immortalized by and producing human T-cell leukemia virus type-I","volume":"38","author":"Nakamura","year":"1986","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymthe.2024.05.020_bib18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1742-4690-10-118","article-title":"Characterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 infection","volume":"10","author":"Miura","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.ymthe.2024.05.020_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01518-23","article-title":"HTLV-1 Proliferation after CD8+ cell depletion by monoclonal anti-CD8 antibody administration in latently HTLV-1-infected cynomolgus macaques","volume":"11","author":"Nakamura-Hoshi","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ymthe.2024.05.020_bib20","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1128\/jvi.68.10.6323-6331.1994","article-title":"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in\u00a0vitro and in\u00a0vivo by peptide immunization","volume":"68","author":"Tanaka","year":"1994","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib21","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.vaccine.2022.03.008","article-title":"Sendai virus particles carrying target virus glycoproteins for antibody induction","volume":"40","author":"Ishii","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2024.05.020_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1073779","article-title":"Advances in preventive vaccine development against HTLV-1 infection: A systematic review of the last 35 years","volume":"14","author":"Santana","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib23","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1002\/j.1460-2075.1987.tb02660.x","article-title":"Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection","volume":"6","author":"Shida","year":"1987","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2024.05.020_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/aid.1995.11.307","article-title":"Highly attenuated HTLV type I env poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits","volume":"11","author":"Franchini","year":"1995","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.ymthe.2024.05.020_bib25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<300::AID-IJC27>3.0.CO;2-J","article-title":"Expression and immunogenicity in rats of recombinant adenovirus 5 DNA plasmids and vaccinia virus containing the HTLV-I env gene","volume":"71","author":"Kazanji","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymthe.2024.05.020_bib26","doi-asserted-by":"crossref","first-page":"e0162323","DOI":"10.1128\/jvi.01623-23","article-title":"An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits","volume":"98","author":"Tu","year":"2024","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib27","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1126\/science.6980467","article-title":"Transformation of human leukocytes by cocultivation with an adult T\u00a0cell leukemia virus producer cell line","volume":"217","author":"Yamamoto","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.05.020_bib28","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1080115","article-title":"Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton","volume":"299","author":"Igakura","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.05.020_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm.2065","article-title":"Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses","volume":"16","author":"Pais-Correia","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.05.020_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000788","article-title":"Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors","volume":"6","author":"Mazurov","year":"2010","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2024.05.020_bib31","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/infdis\/175.3.716","article-title":"Neutralizing activity and antibody reactivity toward immunogenic regions of the human T\u00a0cell leukemia virus type I surface glycoprotein in sera of infected patients with different clinical states","volume":"175","author":"Astier-Gin","year":"1997","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.05.020_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.921606","article-title":"A protective role of HTLV-1 gp46-specific neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies in progression to adult T-cell leukemia (ATL)","volume":"13","author":"Tanaka","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib33","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1099\/0022-1317-83-6-1377","article-title":"Primary replication of a recombinant Sendai virus vector in macaques","volume":"83","author":"Kano","year":"2002","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib34","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1084\/jem.20040432","article-title":"Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial","volume":"199","author":"Matano","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2024.05.020_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1099-1654(199904\/06)9:2<83::AID-RMV244>3.0.CO;2-5","article-title":"Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding","volume":"9","author":"Nagai","year":"1999","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib36","doi-asserted-by":"crossref","first-page":"9710","DOI":"10.1128\/JVI.77.17.9710-9715.2003","article-title":"Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model","volume":"77","author":"Takeda","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib37","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1016\/j.vaccine.2008.09.074","article-title":"Evaluation of the immunogenicity of replication-competent V-knocked-out and replication-defective F-deleted Sendai virus vector-based vaccines in macaques","volume":"26","author":"Takeda","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2024.05.020_bib38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/v8070191","article-title":"Heat Shock Enhances the Expression of the Human T Cell Leukemia Virus Type-I (HTLV-I) Trans-Activator (Tax) Antigen in Human HTLV-I Infected Primary and Cultured T Cells","volume":"8","author":"Kunihiro","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2024.05.020_bib39","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1182\/blood.V76.8.1657.1657","article-title":"Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits","volume":"76","author":"Kataoka","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.05.020_bib40","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/infdis\/164.6.1193","article-title":"Immunoglobulin prophylaxis against milkborne transmission of human T\u00a0cell leukemia virus type I in rabbits","volume":"164","author":"Sawada","year":"1991","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.05.020_bib41","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0264-410X(97)00055-8","article-title":"Prophylaxis of experimental HTLV-I infection in cynomolgus monkeys by passive immunization","volume":"15","author":"Akari","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2024.05.020_bib42","first-page":"74","article-title":"The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in\u00a0vivo transmission of HTLV-1 to human T\u00a0cells in NOD-SCID\/\u03b3cnull (NOG) mice","volume":"11","author":"Saito","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.ymthe.2024.05.020_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/v8020041","article-title":"A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I","volume":"8","author":"Fujii","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2024.05.020_bib44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijc.2910330302","article-title":"In\u00a0vitro antibody-dependent cellullar cytotoxicity against human T-cell leukemia\/lymphoma virus (HTLV)-producing cells","volume":"33","author":"Miyakoshi","year":"1984","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymthe.2024.05.020_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010416","article-title":"NK cells and monocytes modulate primary HTLV-1 infection","volume":"18","author":"Moles","year":"2022","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2024.05.020_bib46","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood.V95.4.1386.004k22_1386_1392","article-title":"Abundant tax protein expression in CD4+ T\u00a0cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes","volume":"95","author":"Hanon","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.05.020_bib47","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.4049\/jimmunol.173.8.5121","article-title":"The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T\u00a0cell lymphotropic virus type 1","volume":"173","author":"Vine","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib48","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.4049\/jimmunol.177.8.5718","article-title":"Reduced frequency, diversity, and function of human T\u00a0cell leukemia virus type 1-specific CD8+ T\u00a0cell in adult T\u00a0cell leukemia patients","volume":"177","author":"Kozako","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib49","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.4049\/jimmunol.0900069","article-title":"The avidity and lytic efficiency of the CTL response to HTLV-1","volume":"182","author":"Kattan","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib50","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.05.020_bib51","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP","volume":"4","author":"Nagai","year":"1998","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.ymthe.2024.05.020_bib52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2024.05.020_bib53","article-title":"Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8+ T\u00a0cell responses","volume":"3","author":"Ishii","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ymthe.2024.05.020_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/JCM.02254-14","article-title":"Identification of TL-Om1, an adult T-cell leukemia (ATL) cell line, as reference material for quantitative PCR for human T-lymphotropic virus 1","volume":"53","author":"Kuramitsu","year":"2015","journal-title":"J.\u00a0Clin. Microbiol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162400323X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162400323X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T12:02:33Z","timestamp":1737633753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162400323X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S152500162400323X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.05.020","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}]}}